Wealth Enhancement Advisory Services LLC Acquires 33,093 Shares of Koninklijke Philips (NYSE:PHG)

Wealth Enhancement Advisory Services LLC boosted its position in Koninklijke Philips (NYSE:PHG - Free Report) by 57.7% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 90,477 shares of the technology company's stock after purchasing an additional 33,093 shares during the period. Wealth Enhancement Advisory Services LLC's holdings in Koninklijke Philips were worth $2,960,000 at the end of the most recent quarter.

Several other large investors have also recently bought and sold shares of PHG. Kitching Partners LLC grew its stake in shares of Koninklijke Philips by 3.4% in the second quarter. Kitching Partners LLC now owns 10,802 shares of the technology company's stock worth $272,000 after purchasing an additional 356 shares during the last quarter. Bruce G. Allen Investments LLC lifted its holdings in Koninklijke Philips by 6.1% during the 2nd quarter. Bruce G. Allen Investments LLC now owns 6,590 shares of the technology company's stock worth $166,000 after buying an additional 381 shares during the period. Riverwater Partners LLC grew its position in shares of Koninklijke Philips by 3.4% in the 2nd quarter. Riverwater Partners LLC now owns 16,201 shares of the technology company's stock valued at $408,000 after buying an additional 534 shares during the last quarter. Holderness Investments Co. increased its stake in shares of Koninklijke Philips by 3.4% in the second quarter. Holderness Investments Co. now owns 16,807 shares of the technology company's stock valued at $424,000 after buying an additional 546 shares during the period. Finally, EverSource Wealth Advisors LLC raised its position in shares of Koninklijke Philips by 7.3% during the second quarter. EverSource Wealth Advisors LLC now owns 8,084 shares of the technology company's stock worth $204,000 after acquiring an additional 550 shares during the last quarter. 13.67% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

PHG has been the topic of several analyst reports. Jefferies Financial Group upgraded Koninklijke Philips from an "underperform" rating to a "hold" rating in a report on Tuesday. StockNews.com raised shares of Koninklijke Philips from a "hold" rating to a "buy" rating in a research note on Monday, July 15th. Four equities research analysts have rated the stock with a hold rating and two have given a buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of "Hold".

Koninklijke Philips Trading Up 1.1 %

NYSE PHG traded up $0.29 during trading hours on Friday, hitting $26.49. 1,092,180 shares of the company's stock were exchanged, compared to its average volume of 912,962. Koninklijke Philips has a 1-year low of $19.49 and a 1-year high of $32.91. The company has a current ratio of 1.16, a quick ratio of 0.74 and a debt-to-equity ratio of 0.60. The stock has a 50-day simple moving average of $30.78 and a 200 day simple moving average of $27.95. The firm has a market cap of $24.90 billion, a price-to-earnings ratio of -63.07, a PEG ratio of 0.92 and a beta of 0.77.

Koninklijke Philips Profile

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.